Evolving Concepts in Salivary Duct Carcinoma: A Narrative Review

Author
Masalunga, Marvin C
Bradley, Patrick J
van Herpen, Carla
Nagao, Toshitaka
Stenman, Göran
Vander Poorten, Vincent
Hellquist, Henrik
Di Palma, Silvana
Leivo, Ilmo
Ferlito, Alfio
Skálová, Alena
Publication date
2026Published in
Oncology and TherapyPublisher / Publication place
Springer Internat. Publ.ISBN / ISSN
ISSN: 2366-1070ISBN / ISSN
eISSN: 2366-1089Funding Information
MSM//LX22NPO5102
UK//COOP
Metadata
Show full item recordCollections
This publication has a published version with DOI 10.1007/s40487-026-00447-6
Abstract
Salivary duct carcinoma (SDC) is an aggressive neoplasm that typically involves the major salivary glands. This rapidly growing tumor is known to recur and metastasize to the neck nodes and to distant sites. Given its poor prognosis, researchers have focused on identifying factors and driver genomic alterations that may account for its behavior, ultimately yielding potential therapeutic targets. This review summarizes the growing body of knowledge on SDC since the publication of the latest WHO Classification of Tumors of the Head and Neck. Updates on emerging subtypes, immunohistochemical profiles, molecular alterations, and potential therapeutic targets are succinctly presented. Findings from studies on tumor immune microenvironment (TIME), which may have implications for the treatment and prognosis of SDC, are also discussed in this narrative review.
Keywords
Androgen receptor, Genetic alterations, HER2 expression, Molecular landscape, Salivary duct carcinoma, Tumor immune microenvironment
Permanent link
https://hdl.handle.net/20.500.14178/3827License
Full text of this result is licensed under: Creative Commons Uveďte původ-Neužívejte dílo komerčně 4.0 International
